Description
The p.R1632C pathogenic mutation (also known as c.4894C>T), located in coding exon 27 of the SCN5A gene, results from a C to T substitution at nucleotide position 4894. The arginine at codon 1632 is replaced by cysteine, an amino acid with highly dissimilar properties, and is located in the DIV-S4 transmembrane region. This variant has been detected in unrelated probands with Brugada syndrome (BrS) and has shown some segregation with disease in families (Nakajima T et al. Heart Rhythm, 2015 Nov;12:2296-304; García-Molina E et al. Mol Med Rep, 2016 Jun;13:4677-80; Monasky MM et al. Front Physiol, 2019 May;10:666). Internal structural analysis indicates that the arginine impacted by this alteration is part of a highly conserved set of residues that generate a characteristic motif necessary to the function of voltage-sensing channels (Gandhi CS et al. J. Gen. Physiol., 2002 Oct;120:455-63; Starace DM et al. Nature, 2004 Feb;427:548-53). In vitro functional studies have indicated that this variant may impact channel kinetics, and a deep mutational scanning study categorized this alteration as a possible loss of function alteration (Nakajima T et al. Heart Rhythm, 2015 Nov;12:2296-304; Glazer AM et al. Circ Genom Precis Med, 2020 02;13:e002786). Other variants affecting this codon (p.R1632H, c.4895G>A and p.R1632L, c.4895G>T) have also been reported in association with arrhythmias, including Brugada syndrome (Benson DW et al. J. Clin. Invest. 2003;112:1019-28; Batchvarov VN et al. J Electrocardiol;44:308). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | unknown | 1 | not provided | not provided | | 1 | not provided | not provided | not provided |